{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:18:01Z","timestamp":1785406681553,"version":"3.56.0"},"reference-count":60,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research, Development and Innovation Office","award":["152766"],"award-info":[{"award-number":["152766"]}]},{"award":["152766"],"award-info":[{"award-number":["152766"]}],"id":[{"id":"https:\/\/ror.org\/03g2am276","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Spondyloarthritis associated with inflammatory bowel diseases (IBD-SpA), also known as enteropathic arthritis, is an independent entity belonging to the spondyloarthritis (SpA) group. In recent years, a great amount of new data has been published regarding the pathogenesis and treatment of the disease. In this narrative review we present the main pathogenetic pathways along the gut\u2013joint axis, the genetics of IBD and SpA, the role of environmental factors and that of the microbiome, as well as the main immunopathological processes including immune cells and inflammatory mediators. We cover the clinical picture, the specifics of axial and peripheral SpA-IBD, and briefly discuss the diagnostics. There are common options in the pharmacotherapy of SpA and IBD; however, some drugs that control arthritis (e.g., NSAIDs, IL-17 inhibitors) might not be suitable for the treatment of IBD. Based on the pathogenetic role of the microbiome, it is suggested that pharmacotherapy can be supplemented with non-pharmacological remedies, such as diet including the administration of short-chain fatty acids (SCFAs). Finally, we briefly look at the future that might include rational, even personalized treatment.<\/jats:p>","DOI":"10.3390\/jcm15124680","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:27:21Z","timestamp":1781666841000},"page":"4680","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory Bowel Disease-Associated Spondyloarthritis"],"prefix":"10.3390","volume":"15","author":[{"given":"Edit","family":"V\u00e9gh","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeka","family":"Falcsik","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Bodn\u00e1r","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3550-5743","authenticated-orcid":false,"given":"Szilvia","family":"Szamosi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Sz\u00e1nt\u00f3","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"},{"name":"Department of Sports Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-9531","authenticated-orcid":false,"given":"Gabriella","family":"Sz\u0171cs","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7794-6844","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"103853","DOI":"10.1016\/j.autrev.2025.103853","article-title":"Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis","volume":"24","author":"Akiyama","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"103443","DOI":"10.1016\/j.autrev.2023.103443","article-title":"SpA plus IBD or IBD plus SpA: Does commutative property apply?","volume":"22","author":"Carubbi","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"631408","DOI":"10.1155\/2013\/631408","article-title":"Enteropathic spondyloarthritis: From diagnosis to treatment","volume":"2013","author":"Peluso","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.autrev.2013.06.006","article-title":"Rheumatic manifestations in inflammatory bowel disease","volume":"13","author":"Atzeni","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/annrheumdis-2014-205253","article-title":"The epidemiology of extra-articular manifestations in ankylosing spondylitis: A population-based matched cohort study","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/rheumatology\/keaa692","article-title":"Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: Results from a national register-based cohort study","volume":"60","author":"Bengtsson","year":"2021","journal-title":"Rheumatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/rheumatology\/keu388","article-title":"Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS","volume":"54","author":"Essers","year":"2015","journal-title":"Rheumatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/annrheumdis-2013-203854","article-title":"Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: Results from the GIANT cohort","volume":"73","author":"Jans","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: A multiparametric predictive model","volume":"72","author":"Jacques","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3748\/wjg.v25.i18.2162","article-title":"Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment","volume":"25","author":"Fragoulis","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s10067-022-06201-3","article-title":"Reflecting on the immunopathology of arthritis associated with inflammatory bowel disease: What do we know and what should we know?","volume":"41","author":"Amarnani","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_14","first-page":"987","article-title":"Extraintestinal manifestations and complications in inflammatory bowel disease: From shared genetics to shared biological pathways","volume":"20","author":"Janse","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jbspin.2009.02.006","article-title":"The genetic background of ankylosing spondylitis","volume":"76","author":"Vegvari","year":"2009","journal-title":"Jt. Bone Spine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e141868","DOI":"10.1172\/jci.insight.141868","article-title":"PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis","volume":"5","author":"Hsieh","year":"2020","journal-title":"JCI Insight"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41584-021-00652-9","article-title":"Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases","volume":"17","author":"Szekanecz","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Danoy, P., Pryce, K., Hadler, J., Bradbury, L.A., Farrar, C., Pointon, J., Australo-Anglo-American Spondyloarthritis Consortium, Ward, M., Weisman, M., and Reveille, J.D. (2010). Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn\u2019s disease. PLoS Genet., 6.","DOI":"10.1371\/journal.pgen.1001195"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41584-020-0454-9","article-title":"Revisiting the gut-joint axis: Links between gut inflammation and spondyloarthritis","volume":"16","author":"Gracey","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jbspin.2016.04.005","article-title":"Gut microbiota and inflammatory joint diseases","volume":"83","author":"Breban","year":"2016","journal-title":"Jt. Bone Spine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","article-title":"Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1177\/2050640619867555","article-title":"Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences","volume":"7","author":"Salem","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e003820","DOI":"10.1136\/rmdopen-2023-003820","article-title":"Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases","volume":"10","author":"Fatica","year":"2024","journal-title":"RMD Open"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.3260","article-title":"How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy","volume":"19","author":"Schett","year":"2013","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"kyae005","DOI":"10.1093\/discim\/kyae005","article-title":"Elevated type-17 cytokines are present in axial spondyloarthritis stool","volume":"3","author":"Brough","year":"2024","journal-title":"Discov. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1172\/JCI119389","article-title":"Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion","volume":"99","author":"Salmi","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.gtc.2014.05.012","article-title":"Lymphocyte homing antagonists in the treatment of inflammatory bowel diseases","volume":"43","author":"Saruta","year":"2014","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.181.1.137","article-title":"Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: Dissection of the molecular mechanisms","volume":"181","author":"Salmi","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1566524043479310","article-title":"The histopathology of spondyloarthropathy","volume":"4","author":"Baeten","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-4419-0298-6_5","article-title":"Synovial and mucosal immunopathology in spondyloarthritis","volume":"649","author":"Vandooren","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12178-011-9085-8","article-title":"Inflammatory bowel disease associated arthropathy","volume":"4","author":"Arvikar","year":"2011","journal-title":"Curr. Rev. Musculoskelet. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e001558","DOI":"10.1136\/rmdopen-2020-001558","article-title":"The arthritis connection to inflammatory bowel disease (IBD): Why has it taken so long to understand it?","volume":"7","author":"Ashrafi","year":"2021","journal-title":"RMD Open"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"152890","DOI":"10.1016\/j.semarthrit.2025.152890","article-title":"Self-administered screening questionnaires for spondyloarthritis in inflammatory bowel disease: A systematic review","volume":"76","author":"Schotkosky","year":"2026","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10067-017-3937-6","article-title":"The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: Development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis","volume":"37","author":"Luchetti","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/ecco-jcc\/jjaa096","article-title":"The IBIS-Q [IBd Identification of Spondyloarthritis Questionnaire]: A Novel Tool to Detect Both Axial and Peripheral Arthritis in Inflammatory Bowel Disease Patients","volume":"14","author":"Variola","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3899\/jrheum.161216","article-title":"Detection of Crohn Disease in Patients with Spondyloarthropathy: The SpACE Capsule Study","volume":"45","author":"Kopylov","year":"2018","journal-title":"J. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.autrev.2015.11.002","article-title":"Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients","volume":"15","author":"Conigliaro","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"103512","DOI":"10.1016\/j.autrev.2023.103512","article-title":"Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases","volume":"23","author":"Ondrejcakova","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"ref_39","first-page":"S178","article-title":"Imaging and scoring in ankylosing spondylitis","volume":"20","author":"Braun","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jbspin.2007.04.001","article-title":"Imaging for the diagnosis and follow-up of ankylosing spondylitis: Development of recommendations for clinical practice based on published evidence and expert opinion","volume":"74","author":"Pavy","year":"2007","journal-title":"Jt. Bone Spine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.62347\/YXQT2560","article-title":"18F-FDG-PET and other imaging modalities in the diagnosis and management of inflammatory bowel disease","volume":"14","author":"Bhattaru","year":"2024","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1759720X20939410","DOI":"10.1177\/1759720X20939410","article-title":"IBD considerations in spondyloarthritis","volume":"12","author":"Raine","year":"2020","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11894-025-00990-8","article-title":"Practical Tips for Diagnosis and Management of Concomitant Inflammatory Spondyloarthritis and Inflammatory Bowel Disease","volume":"27","author":"Falloon","year":"2025","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41584-023-00984-8","article-title":"Spondyloarthritis with inflammatory bowel disease: The latest on biologic and targeted therapies","volume":"19","author":"Cozzi","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1172\/JCI128521","article-title":"The gut-bone axis: How bacterial metabolites bridge the distance","volume":"129","author":"Zaiss","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/00365521.2014.966753","article-title":"Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease","volume":"50","author":"Kvasnovsky","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Miao, X.P., Li, J.S., Ouyang, Q., Hu, R.W., Zhang, Y., and Li, H.Y. (2014). Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. Cochrane Database Syst. Rev., CD007744.","DOI":"10.1002\/14651858.CD007744.pub2"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/apt.14606","article-title":"Systematic review with meta-analysis: Association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn\u2019s disease and ulcerative colitis exacerbation","volume":"47","author":"Moninuola","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S1542-3565(05)00759-7","article-title":"Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn\u2019s disease","volume":"3","author":"Agrawal","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: Unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.immuni.2015.10.001","article-title":"Gut-Busters: IL-17 Ain\u2019t Afraid of No IL-23","volume":"43","author":"Whibley","year":"2015","journal-title":"Immunity"},{"key":"ref_53","first-page":"275","article-title":"Natalizumab in the treatment of Crohn\u2019s disease","volume":"2","author":"Guagnozzi","year":"2008","journal-title":"Biologics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/1744666X.2023.2214728","article-title":"The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease","volume":"19","author":"Gupta","year":"2023","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(22)00427-7","article-title":"Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): A randomised, double-blind, controlled, phase 2, proof-of-concept trial","volume":"8","author":"Feagan","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"103865","DOI":"10.1016\/j.autrev.2025.103865","article-title":"Combination targeted therapy with two biologic\/targeted synthetic DMARDs in 1200 patients with immune mediated inflammatory diseases. A systematic literature review for current landscape in safety and efficacy","volume":"24","author":"Lignou","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ecco-jcc\/jjy125","article-title":"Incidence of Arthritis\/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials","volume":"13","author":"Feagan","year":"2019","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41584-020-0377-5","article-title":"Moving towards a systems-based classification of innate immune-mediated diseases","volume":"16","author":"Savic","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103533","DOI":"10.1016\/j.autrev.2024.103533","article-title":"The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus","volume":"23","author":"Macaluso","year":"2024","journal-title":"Autoimmun. Rev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4680\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:22:06Z","timestamp":1782274926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124680"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124680","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}